chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Felt their legs were numb; Weakness; Extreme fatigue; Headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Felt their legs were numb), ASTHENIA (Weakness), FATIGUE (Extreme fatigue) and HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     The patient's past medical history included COVID-19.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (Felt their legs were numb), ASTHENIA (Weakness), FATIGUE (Extreme fatigue) and HEADACHE (Headache). At the time of the report, HYPOAESTHESIA (Felt their legs were numb), ASTHENIA (Weakness), FATIGUE (Extreme fatigue) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Dec-2020, SARS-CoV-2 test positive: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment information provided.
Received dose from vial punctured more than 12 hours before; This spontaneous case was reported by a medical assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received dose from vial punctured more than 12 hours before) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 077C21B) for COVID-19 vaccination.     Concurrent medical conditions included GERD and Pain. Concomitant products included FAMOTIDINE from 02-Sep-2021 to an unknown date for GERD, IBUPROFEN and HYDROCODONE BITARTRATE, PARACETAMOL (HYDROCODONE/ACETAMINOPHEN) from 15-Mar-2021 to an unknown date for Pain.    On 29-Nov-2021 at 9:30 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 29-Nov-2021 at 9:30 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Received dose from vial punctured more than 12 hours before). On 29-Nov-2021 at 9:30 AM, EXPIRED PRODUCT ADMINISTERED (Received dose from vial punctured more than 12 hours before) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient received .25mL of Moderna on 11/29/21. The vial used was opened/punctured on 11/26/21 at 3:40pm and put the vial back in the fridge. Vials did not undergo any temperature excursion and was punctured only three times. Patient has not had any adverse reaction.    This case was linked to MOD-2021-400131 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 01-Dec-2021: Follow up received: Patient demographics, dosage detail updated,  Medical history and con-med details added
This case was reported by a healthcare professional to a sales representative and described the occurrence of swelling at the injection site in a 4 year old male subject who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix, GlaxoSmithKline) for prophylaxis. On 05 September, the subject received a dose of Infanrix (dose number and lot number not reported). Following administration of Infanrix, 05 September 2006, the subject experienced swelling at the injection site. At the time of reporting, 06 September 2006, the event was ongoing. The healthcare professional considered the event was probably related to vaccination with Infanrix. Follow-up information received on on 22 September 2006 indicated that the event began on 05 September 2006 and was resolved by 12 September 2006. The Infanrix dose received prior to the reaction was the subject's 5th dose in the series. The reporter considered the event to be related to Infanrix.
Vomiting, severe diarrhea, haven?t eaten n two days, still diarrhea
There was a small red dot, now its a fairly large red area and its hard, it was painful to lift my arm,I had chills and temp of 102.8 on the 3rd day after the vaccine.  Also, I tested positive for covid on 1/23/2021 and on 2/6 and had pneumonia on 2/6/2021.
Unknown details of vaccination - patient states 2nd vaccine was given at least 3 weeks ago. Transferred to this facility from another location. on 7/2/2021 - with diagnosis of abdominal pain x 2 weeks. US shows gallbladder sludge and positive Murphy sign. Tested for COVID prior to transfer (not sure where) and is positive. No cough, fever, SOB or other symptoms. Patient is still inpatient 7/6/2021
injection site bleeding; underdose; This case was reported by a pharmacist via call center representative and described the occurrence of injection site hemorrhage in a 75-year-old male patient who received Herpes zoster (Shingrix) (batch number 2Y9R4, expiry date 28th June 2021) for prophylaxis.   On 26th March 2019, the patient received the 1st dose of Shingrix. On 26th March 2019, less than a day after receiving Shingrix, the patient experienced injection site hemorrhage (serious criteria GSK medically significant) and underdose. On an unknown date, the outcome of the injection site hemorrhage and underdose were unknown.   It was unknown if the reporter considered the injection site hemorrhage to be related to Shingrix.  Additional details were provided as follows: The patient experienced bleeding at the injection site. The health care professional felt like he had not received the full dose of Shingrix, which led to underdose and asked if an additional dose was needed. On 12th June 2019, the patient received the 2nd dose of Shingrix.
Similar to a pinched nerve, but I don't recall doing anything that would "pinch" a nerve.  The day after the second dose of moderna, my left arm ached at night.  It has continued to fell numb, tingly, and achy, most predominant when I lie down.  It has been steady pain for a week and 1/2 now.  Worst pain occurs in the evening when lying  flat on back.  Can not lay on either side when in bed, has to be on back.
Pfizer 5/23/21, 6/13/21. Positive on 2/8/22
Shortly after vaccination complained of itchiness to face and throat. Symptoms progressed. Received Benedryl 50mg orally followed by Epinephrine 0,3 IM.  Transported to hospital
Difficulty breathing/wheezing, rapid heart rate, dizziness. Used an Albuterol inhaler for wheezing and took 25mg of Benadryl.
Local itching at injection site within 12 hours with duration 7 days for JEV #1 and JEV #2.  Reports worsening of osteoarthritis in May and June following JEV #1 & JEV #2.
Initial report received from a health care professional on 16 November 2010. A 53-year-old female patient received on 23 September 2009 at 7:30 AM an intramuscular injection (site not reported) of FLUZONE, lot number U3196AA. The patient had no known allergies. The patient's medical history was not reported and her concomitant medications were not provided. She had no illness at the time of vaccination. She had no H1N1 in the past and no previous vaccination at her present location. On 23 September 2009 at 11:00 AM the patient developed scratchy eyes with decreased vision and milky drainage from both eyes for 5 hours. The outcome was reported as recovered. Documents held by sender: None.
Patient states soreness at site of injection, malaise, low grade temperature (less than or equal to 98.7).
Sore left arm accompanied with a red bump the size of a quarter, mild headache, and fever of 100.8.
Fever (99.9), Redness at injection site, warmth, nausea and fatigue. Patient states she feels better today, but the site is still warm and red. Donor is using a cold compress at the area.
Within about 10 minutes I started to experience a tingling sensation in my head (much like my reaction to MSG) as well as difficulty concentrating and slight dizziness; 15 hours later (3am Thurs morning) I began vomiting - this continued about every hour for the next ten hours. During this time I had chills, a fever of about 101, muscle ache, but no headache. The nausea continued for the remainder of the day. On Friday I had a headache, slight nausea, fatigue, the symptoms were similar on Saturday and again today.
Pt recv vax on 4/16/99; 1 min post vax pt exp raised, blanched area above rt knee, incr to vax site; tx=ice, Temovate
4 days post vax-diarrhea, severe nausea, vomit, cannot tolerate sun exposure or heat, dizzy, low grade temp, h/a, pain in back of neck going down back;
Pt had joint pain in various places for about a week, 2 weeks following the 2nd shot.  Ibuprofen helped. Pain went away 1-2 weeks. Unclear if this is related to the shot or not but would appreciate some guidance about getting a booster.
17 years old; This spontaneous case was reported by a patient and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years old) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years old). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years old) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       There is no concomitant list. There is no product complaint associated with this case
This spontaneous report as received from a Certified Medical Assistant refers to a patient of unknown age and gender. It was reported that the patient received a first dose of both VARIVAX (route, lot number and expiration date not reported) and PROQUAD (route, lot number and expiration date not reported) on 09-JUN-2014. No adverse symptoms reported. Additional information has been requested.
AE: muscle pain, radiating to underarm and elbow, swollen brachial LN begining 4 hours post vaccination, increasing in severity for 24 hours then resolving 72 hours later. Tx: NSAID's (Ibuprofen) 400 mg q 8 hours, ice alternated w/ warm compress q 4 hours.
Severe migraines with vertigo every day. Neurologist prescribed two rounds of steroids. Symptoms relieved during treatment but return immediately afterwards.
Within 5 minutes Iduirng the resting period of 20 minutes I had increased heart rate and blood pressure.  My Apple watch alerted me to the changes.  Later driving home sharp pain in the lymph nodes in the left armpit pain which extended into the area under the left breast implant.  At this time ache continues (3/23/21)
Information has been received from a medical student concerning a female with no medical history or allergy who in the past was vaccinated with MMR II. There was no concomitant medication. The patient had a low measles titer. The medical student was not sure if the patient had received one of two doses of MMR II. The lab studies were performed with titers. The patient sought unspecified medical attention. Follow-up information has been received from a physician who reported the patient had received MMR II and measles titers showed ineffective titers. They did not administer the vaccine, it was done by prior pediatrician. The patient had recovered. Follow-up information has been received from a physician of the pediatric group who reported that the patient had not been seen since 2004. No further information is available.
Mild soreness in my left arm where the shot was administered; This is a spontaneous report from a contactable consumer (patient). A 26-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EL3247) via an unspecified route of administration in the left arm on 03Feb2021 at 14:45 (at the age of 26-years-old) as single dose for COVID-19 immunization. Vaccination facility was a Workplace clinic. The patient had no medical history. The patient was not allergic to medications, food or other products. Concomitant medications were not provided. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine nor any other medications within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 prior vaccination. On 03Feb2021 at 08:00 PM (same day of vaccination), patient experienced mild soreness in left arm where the shot was administered. No treatment was received for the event. Since the vaccination, the patient not tested for COVID-19. The outcome of the event was recovering.   Follow-up attempts are completed. No further information is expected.
shingles; This spontaneous report has been received from a lawyer, regarding a case in litigation and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On or about 25-SEP-2012, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, anatomical location, lot # and expiry date were not provided), as prescribed and/or administered by a pharmacist at a pharmacy for the long-term prevention of shingles and zoster-related conditions. Subsequent to the patient's zoster vaccine live (ZOSTAVAX) inoculation, on an unknown date, the patient was treated by a physician for shingles. As a direct and proximate result of the patient's use of the zoster vaccine live (ZOSTAVAX) vaccine, the patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future. The outcome of shingles was considered to be not recovered. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).
pt recv vax 20MAR96 & 5JUN96 pt exp a typical vesicular-papular chicken pox rash, primarily on head & trunk;
SEVERE SORE THROAT, TROUBLE SWALLOWING 3 HOURS AFTER VACCINE, WENT TO URGENT CARE AND WAS GIVEIN BENADRYL AND RANITIDINE. THROAT ISSUES RESOLVED QUICKLY BUT HAD  FLU-LIKE SYMPTOMS IN EVENING AND HEADACHE NEXT MORNING. TOOK IBUPROPHEN AND ALL RESOLVED. ON OCTOBER 16, ABOUT 2AM, WHILE PREPARING FOR COLONOSCOPY, NOTICED BRUISES AND PETECHIAE ON LEGS. WENT TO GI CLINIC NEXT MORNING WHERE THEY DID BLOOD WORK AND FOUND THAT I HAD NO PLATELETS. I WAS HOSPITALIZED FOR AND DIAGNOSED WITH IMMUNE THROMBOCYTOPENIC PURPURA (ITP). TREATED WITH PLATELET TRANSFUSION AND HIGH DOSE STERIODS.
Severely sore left arm 24 to 48 hours after vaccine administration. Resolved by 72 hour Severe fatigue that persisted to 5 days post-vaccine Sore throat Headache -- but I am a migraine sufferer and I have an acoustic neuroma so unsure this is vaccine related Dizzyness -- persisted to Day 5 post-vaccine Day-time sleepiness -- more than usual  Night time -- poor sleep cycle; had that for 1-2 days after doses 1-3; still have this after Day 4. Today is Day 5
Patient presented a few hours after administration with soreness in arm. Twenty-four hours later she presented with redness, swelling, warmness and pain in entire upper half of left arm.
I have greatly reduced hearing in both ears that has persisted for over 10 days. Feeling of fullness/pressure in the ears, throbbing pain in both ears at times, and generally muffled sounds. I can?t ?pop? my ears like I?ve been able to do my entire life.
12 month old vaccines on 7/12/12, developed papular eruption with new lesions coming 7/18/12.
I started to feel a "lump" that was warm to touch earlier in the day at the injection site about 730PM in the evening on 12/2/21. I started to get rapid, intense pain at the injection site with radiating pain down my forearm and to my fingers on the left arm.  I also experienced intense pain to the left side of my chest and ribs with intermittent prodding/stabbing pain that felt like voltage (10/10 scale).  This was intermittent for approximately 70 min.  It has subsided to a tolerable level at this point (4/10 scale); and felt it was best to report.  I am keeping icepacks on to alleviate pain.  I am also currently experiencing droning/hissing sound in my left ear - this has not subsided.   The left ear rining/hissing is something I also experienced after my 2nd dose.
Redness and swelling around arm below injection site of PNEUMOVAX. Patient also reported a fever, muscle weakness, aches/pains, headache, and pain/tenderness at PNEUMOVAX injection site (note, she also received a FLUAD vaccine the same day, but in the right arm, which did not have any redness/swelling/pain at injection site).
pt began to feel lightheaded after leaving pharmacy area 20 minutes later and sat in car for 1 1/4 hours, arm sore and red starting next day and still a small red sport with soreness today
Patient came in complaining of arm soreness from flu shot given 10/8/12. Claims shot was given too high on shoulder. He has alot of arm pain causing insomnia for last 11 days. When sitting in chair he has to use other arm to lift the arm where shot was given but can move it okay when up doing things, just has soreness then. He has appt with his physician this afternoon.
PATIENT IS 11 YEARS OLD AND RECIEVED THE VACCINE INTENDED FOR ADULTS 12 AND OLDER.
Hives came up on the kid's face, 23 hours after multiple vaccines that were given. Called the doctor's office they suggested me to give my kid Benadryl.
I had a reaction to the covid vaccine.; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of   in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     The patient's past medical history included No adverse event (No relevant medical history).    On 29-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant medications were provided No treatment information provided
Information has been received from a register nurse concerning a patient of unknown age and gender. There was no concurrent condition, medical history and concomitant therapy reported. On 16-MAY-2016, the patient received a dose of M-M-R II (lot#, dose not provided), intramuscularly rather than subcutaneously. No adverse effect was reported. Follow up information has been received from the physician on 08-AUG-2016. On 16-MAY-2016, patient received second dose of M-M-R II, lot L034930, in the right leg. On 17-MAY-2016, patient experienced redness, itching and swelling. Events were not associated with any of the seriousness criteria. Illness at the time of vaccination was reported as none. The outcome of the events was unknown. Causality assessment was not provided. Additional information has been requested. Product, events and narrative were updated.
Some inflammation in the lungs; Severe shortness of breath/trouble breathing; Pain in the chest; Cough; Excessive tiredness; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of PNEUMONITIS (Some inflammation in the lungs), DYSPNOEA (Severe shortness of breath/trouble breathing), CHEST PAIN (Pain in the chest), COUGH (Cough) and FATIGUE (Excessive tiredness) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 016M21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced PNEUMONITIS (Some inflammation in the lungs) (seriousness criterion hospitalization), DYSPNOEA (Severe shortness of breath/trouble breathing) (seriousness criterion hospitalization), CHEST PAIN (Pain in the chest) (seriousness criterion hospitalization), COUGH (Cough) (seriousness criterion hospitalization) and FATIGUE (Excessive tiredness) (seriousness criterion hospitalization). At the time of the report, PNEUMONITIS (Some inflammation in the lungs), DYSPNOEA (Severe shortness of breath/trouble breathing), CHEST PAIN (Pain in the chest), COUGH (Cough) and FATIGUE (Excessive tiredness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Mar-2021, Oxygen saturation: low Low. On an unknown date, SARS-CoV-2 test: negative (Negative) Tested twice and both tests came negative..         Concomitant medication were not provided.  Treatment included Hospitalization in ER for 2 days  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-137829 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Painful & sore arm, Tinnitus, Ear ringing, Clogged ears, Vertigo, Hives, Insomnia.
The patient was given  the first dose of Moderna by a Medical Assistant with out realizing it was not pfizer.
Initial symptoms were sore throat and nausea the evening of the vaccination (Wednesday, 2/3/21).  Those continued the following day and as the day progressed I also was experiencing a headache, mild achiness, left side of my neck was sore/tender, and then that evening chills and a fever of 101.3.  On Friday, 2/5/21 I woke up with a very sore and swollen right axilla and still had a headache, but the fever resolved over night.  All symptoms, except right axillary swelling/soreness was resolved by the afternoon on 2/6/21.  Currently, on 2/8/21, I still have mild tenderness/soreness in right axilla.
Fever, body aches, and sharp pain radiating from the left shoulder to his forearm causing his 4 fingers to be contracted.
Patient was call back to clinic vital signs were taken and they were wnl. Patient showed no s/s of any distress and when asked he denies any s/s. Provider was informed and also Moderna manufacture was contacted and they will f/u with guidelines.
Redness; Swelling; Itching; Pain in the arm; Heat in the arm; A spontaneous report was received from a nurse concerning an unknown patient who received Moderna's COVID-19 vaccine and experienced redness, swelling, itching, pain in the arm, and heat in the arm.    The patient's medical history was not provided. No relevant concomitant medications were reported.   On 23 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (lot: unknown) intramuscularly for prophylaxis of COVID-19 infection.   On an unknown date, the patient reported redness, swelling, itching, pain in the arm and heat in the arm. No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded